Executive Summary

​​​​All healthcare providers, including (but not limited to) hospitals, ambulatory/surgical centers, long-term care facilities, physician practices, clinics, and dentistry offices, should have an adequate supply of antimicrobial products effective against SARS-CoV-2. The US Centers for Disease Control and Prevention's (CDC) Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic states:

Routine cleaning and disinfection procedures (e.g., using cleaners and water to pre-clean surfaces prior to applying an EPA-registered, hospital-grade disinfectant to frequently touched surfaces or objects for appropriate contact times as indicated on the product's label) are appropriate for SARS-CoV-2 in healthcare settings, including those patient-care areas in which AGPs [aerosol-generating procedures] are performed. Refer to List N on the EPA website for EPA-registered disinfectants that kill SARS-CoV-2; the disinfectant selected should also be appropriate for other pathogens of concern at the facility (e.g., a difficile sporicidal agent is recommended to disinfect the rooms of patients with C. [Clostridioides] difficile infection).

In March 2020, the US Environmental Protection Agency (EPA) published List N: Disinfectants for Use Against SARS-CoV-2. The latest update can be found in EPA's List N Tool: COVID-19 Disinfectants. Manufacturers of reusable, noncritical devices and equipment may recommend the use of certain generic disinfectants (e.g., sodium hypochlorite) at certain concentrations. But List N does not specify disinfectant concentrations.

To help you more easily determine whether any products on the list match manufacturer disinfectant recommendations, we've created a table that includes the disinfectant contact times and use settings from List N, plus an additional column listing each product's disinfectant concentration. To compile this information, we searched EPA product registrations, amendments, master labels, and other applications. As EPA continues to update the List N Tool, we will update our table as needed.

​​​​

Who Should Read This

Table of Contents

Overview​

All healthcare providers, including (but not limited to) hospitals, ambulatory/surgical centers, long-term care facilities, physician practices, clinics, and dentistry offices, should have an adequate supply of antimicrobial products effective against SARS-CoV-2. The US Centers for Disease Control and Prevention's (CDC) Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic states:

Routine cleaning and disinfection procedures (e.g., using cleaners and water to pre-clean surfaces prior to applying an EPA-registered, hospital-grade disinfectant to frequently touched surfaces or objects for appropriate contact times as indicated on the product's label) are appropriate for SARS-CoV-2 in healthcare settings, including those patient-care areas in which AGPs [aerosol-generating procedures] are performed. Refer to List N on the EPA website for EPA-registered disinfectants that kill SARS-CoV-2; the disinfectant selected should also be appropriate for other pathogens of concern at the facility (e.g., a difficile sporicidal agent is recommended to disinfect the rooms of patients with C. [Clostridioides] difficile infection).

In March 2020, the US Environmental Protection Agency (EPA) published List N: Disinfectants for Use Against SARS-CoV-2. The latest update can be found in EPA's List N Tool: COVID-19 Disinfectants. Manufacturers of reusable, noncritical devices and equipment may recommend the use of certain generic disinfectants (e.g., sodium hypochlorite) at certain concentrations. But List N does not specify disinfectant concentrations.

To help you more easily determine whether any products on the list match manufacturer disinfectant recommendations, we've created a table that includes the disinfectant contact times and use settings from List N, plus an additional column listing each product's disinfectant concentration. To compile this information, we searched EPA product registrations, amendments, master labels, and other applications. As EPA continues to update the List N Tool, we will update our table as needed.

 

Download the Table​​

Disinfectant Concentrations, Contact Times, and Use Settings for Products Effective against SARS-CoV-2 (List N)​

Glossary

Bibliography

References

Centers for Disease Control and Prevention (CDC), US. Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic . Updated May 8, 2023. Accessed March 12, 2024. https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html

Environmental Protection Agency (EPA), US. List N Tool: COVID-19 disinfectants.  Accessed March 4, 2024. https://cfpub.epa.gov/wizards/disinfectants/

Resource List

Related Resources

Outbreak Preparedness and Response: The Essentials

Infection Reduction Technologies: The Essentials

Home-Based Health and Hospice Care: The Essentials

Disinfectant Concentrations, Contact Times, and Use Settings for EPA's List of Products Effective against Mycobacterium tuberculosis (List B)

Disinfectant Concentrations and Contact Times for EPA's List of Products Effective against Mycobacterium tuberculosis, Human HIV-1, and Hepatitis B Virus (List E)

Disinfectant Concentrations, Contact Times, and Use Settings for EPA's List of Products Effective against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci (List H)

Disinfectant Concentrations, Contact Times, and Use Settings for EPA's List of Products Effective against Clostridioides difficile (List K)

Disinfectant Concentrations, Contact Times, and Use Settings for EPA's List of Products Effective against Ebola Virus (List L)

Disinfectant Concentrations, Contact Times, and Use Settings for EPA's List of Products Effective against Candida auris (List P)

Disinfectant Concentrations, Contact Times, and Use Settings for EPA's List of Products Effective against Emerging Viral Pathogens (List Q)​​

Evaluation: Clorox Healthcare Dispatch Hospital Cleaner Disinfectant Towels with Bleach

Evaluation: Clorox Healthcare Hydrogen Peroxide Cleaner Disinfectant Wipes

Evaluation: Diversey Oxivir TB Disinfectant Wipes

Evaluation: Metrex CaviWipes Bleach Disinfectant Wipes

Evaluation: Metrex CaviWipes1 Disinfectant Wipes

Evaluation: PDI Sani-Cloth Bleach Disinfectant Wipes

Evaluation: PDI Super Sani-Cloth Disinfectant Wipes

Topics and Metadata

Topics

Biomedical Engineering; Infection Control; Laws, Regulations, Standards; Long-term Care; Procurement Trends; Quality Assurance/Risk Management; Sterilization and Reprocessing; Physician Preference Items; Technology Management; Inventory Management; Service and Maintenance; Technology Selection; Transitions of Care

Caresetting

Ambulatory Care Center; Ambulatory Surgery Center; Assisted-living Facility; Behavioral Health Facility; Dialysis Facility; Emergency Department; Endoscopy Facility; Home Care; Hospice; Hospital Inpatient; Hospital Outpatient; Imaging Center; Independent Living Facility; Physician Practice; Rehabilitation Facility; Short-stay Facility; Skilled-nursing Facility; Substance Abuse Treatment Facility; Trauma Center

Clinical Specialty

Bariatrics; Critical Care; Emergency Medicine; Hospital Medicine; Internal Medicine; Obstetrics; Oncology; Primary Care; Surgery; Transplantation

Roles

Allied Health Personnel; Biomedical/Clinical Engineer; Clinical Practitioner; Environmental Services Manager; Infection Preventionist; Materials Manager/Procurement Manager; Patient Safety Officer; Quality Assurance Manager; Regulator/Policy Maker; Risk Manager

Information Type

Guidance

Phase of Diffusion

 

Technology Class

 

Clinical Category

 

SourceBase Supplier

Product Catalog

MeSH

ICD9/ICD10

FDA SPN

SNOMED

HCPCS

Disease/Condition

 

Publication History